Murine Model of Chemotherapy-Induced Extraintestinal Pathogenic Escherichia coli Translocation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Infection and Immunity

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.00684-15PMID 26034214PMCID PMC4496622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic use of cyclophosphamide and its cytotoxic action : A challenge for researchers

  2016cited by this paper
• Variations in Organism-Specific Severe Sepsis Mortality in the United States: 1999–2008*

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Pathogenic E. coli Exploits SslE Mucinase Activity to Translocate through the Mucosal Barrier and Get Access to Host Cells

  2015cited by this paper
• SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains

  2014cited by this paper
• Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.

  2013cited by this paper
• UPARSE: highly accurate OTU sequences from microbial amplicon reads

  2013cited by this paper
• Enterotoxigenic Escherichia coli Secretes a Highly Conserved Mucin-Degrading Metalloprotease To Effectively Engage Intestinal Epithelial Cells

  2013cited by this paper
• Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream

  2013cited by this paper
• Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms

  2012cited by this paper
• Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.

  2012cited by this paper
• A Novel Extracellular Metallopeptidase Domain Shared by Animal Host-Associated Mutualistic and Pathogenic Microbes

  2012cited by this paper
• Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance

  2012cited by this paper
• Bacterial translocation contributes to cachexia from locally advanced gastric cancer.

  2012cited by this paper
• The SILVA ribosomal RNA gene database project: improved data processing and web-based tools

  2012cited by this paper
• Detection of Bacterial DNA in Serum from Colon Cancer Patients: Association with Cytokine Levels and Cachexia

  2012cited by this paper
• Virulence of Escherichia coli Clinical Isolates in a Murine Sepsis Model in Relation to Sequence Type ST131 Status, Fluoroquinolone Resistance, and Virulence Genotype

  2012cited by this paper
• The Type II Secretion System and Its Ubiquitous Lipoprotein Substrate, SslE, Are Required for Biofilm Formation and Virulence of Enteropathogenic Escherichia coli

  2012cited by this paper
• Elimination of breast tumor-associated chondroitin sulfate promotes metastasis.

  2011cited by this paper
• Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy

  2011cited by this paper
• Presence of Putative Repeat-in-Toxin Gene tosA in Escherichia coli Predicts Successful Colonization of the Urinary Tract

  2011cited by this paper
• QIIME allows analysis of high-throughput community sequencing data

  2010cited by this paper
• Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli

  2010cited by this paper
• The Emperor of All Maladies: A Biography of Cancer

  2010cited by this paper
• The Pangenome Structure of Escherichia coli: Comparative Genomic Analysis of E. coli Commensal and Pathogenic Isolates

  2008cited by this paper
• E. coli genome manipulation by P1 transduction.

  2007cited by this paper
• Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model.

  2007cited by this paper
• EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

  2006cited by this paper
• Abundance‐Based Similarity Indices and Their Estimation When There Are Unseen Species in Samples

  2006cited by this paper
• UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context

  2006cited by this paper
• Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections

  2006cited by this paper
• Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source.

  2006cited by this paper
• A Mathematical Theory of Communication

  2006cited by this paper
• Transcriptional Regulation of the yghJ-pppA-yghG-gspCDEFGHIJKLM Cluster, Encoding the Type II Secretion Pathway in Enterotoxigenic Escherichia coli

  2006cited by this paper
• Chemotherapy‐induced neutropenia

  2004cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

  2003cited by this paper
• IroN Functions as a Siderophore Receptor and Is a Urovirulence Factor in an Extraintestinal Pathogenic Isolate of Escherichia coli

  2002cited by this paper
• Mutation of the Gene Encoding Cytotoxic Necrotizing Factor Type 1 (cnf1) Attenuates the Virulence of Uropathogenic Escherichia coli

  2001cited by this paper
• Deaths: final data for 1998.

  2000cited by this paper
• Prevalence of Virulence Genes and Clonality inEscherichia coli Strains That Cause Bacteremia in Cancer Patients

  2000cited by this paper
• Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

  2000cited by this paper
• Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women

  2000cited by this paper
• Discovery of disseminated J96-like strains of uropathogenic Escherichia coli O4:H5 containing genes for both PapG(J96) (class I) and PrsG(J96) (class III) Gal(alpha1-4)Gal-binding adhesins.

  1997cited by this paper
• Diagnosis and treatment of uncomplicated urinary tract infection.

  1997cited by this paper
• The history of the oxazaphosphorine cytostatics

  1996cited by this paper
• Acute bacterial meningitis in the newborn.

  1994cited by this paper
• T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract

  1994cited by this paper
• Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

  1994cited by this paper
• Bacterial translocation from the gastrointestinal tract to various segments of the mesenteric lymph node complex

  1994cited by this paper
• Generation of isogenic K54 capsule‐deficient Escherichia coli strains through TnphoA‐mediated gene disruption

  1993cited by this paper
• An extraintestinal, pathogenic isolate of Escherichia coli (O4/K54/H5) can produce a group 1 capsule which is divergently regulated from its constitutively produced group 2, K54 capsular polysaccharide

  1993cited by this paper
• Clinical Pharmacokinetics of Cyclophosphamide

  1991cited by this paper
• Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation.

  1991cited by this paper
• Bacterial translocation from the gastrointestinal tract.

  1990cited by this paper
• Food without fiber promotes bacterial translocation from the gut.

  1990cited by this paper
• Characterization of the Vibrio cholerae ToxR Regulon: Identification of Novel Genes Involved in Intestinal Colonization

  1989cited by this paper
• Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node.

  1988cited by this paper
• Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation.

  1988cited by this paper
• Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation.

  1988cited by this paper
• Evidence for the phagocytic transport of intestinal particles in dogs and rats

  1988cited by this paper
• Role of the macrophage in the translocation of intestinal bacteria.

  1987influential reference
• Translocation of indigenous bacteria from the gastrointestinal tract of mice after oral ricinoleic acid treatment.

  1986cited by this paper
• Increased translocation of bacteria from the gastrointestinal tracts of tumor-bearing mice

  1985cited by this paper
• Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes

  1983cited by this paper
• Bacterial translocation from the gastrointestinal tracts of mice receiving immunosuppressive chemotherapeutic agents

  1983cited by this paper
• National Institute for Occupational Safety and Health: areas of concern.

  1982cited by this paper
• Ischemic injury in the cat small intestine: role of superoxide radicals.

  1982cited by this paper
• Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole

  1981cited by this paper
• Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice

  1980cited by this paper
• Translocation of Certain Indigenous Bacteria from the Gastrointestinal Tract to the Mesenteric Lymph Nodes and Other Organs in a Gnotobiotic Mouse Model

  1979cited by this paper
• Clinical Pharmacokinetics of Cyclophosphamide

  1979cited by this paper
• Clinical Pharmacokinetics of Cyclophosphamide

  1979cited by this paper
• Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.

  1972cited by this paper
• Translocation of microorganisms across the intestinal wall of the rat: effect of microbial size and concentration.

  1966cited by this paper
• Colonization Resistance

  year unknowncited by this paper

• Artisanal food of animal origin as reservoir of putative pathogenic Escherichia coli: a combined genomic and in vivo approach

  2026cites this paper
• Functional Genomics of Gastrointestinal Escherichia coli Isolated from Patients with Cancer and Diarrhea

  2023cites this paper
• Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation.

  2023cites this paper
• Broad protective vaccination against systemic Escherichia coli with autotransporter antigens

  2023cites this paper
• Microbial and host factors contribute to bloodstream infection in a pediatric acute lymphocytic leukemia mouse model

  2022cites this paper
• High Drug Loading Nanoparticles Stabilized with Autologous Serum Proteins Passively Inhibits Tumor Growth.

  2022cites this paper
• Co-delivery nanosystem of Epigallocatechin Gallate and Rutin for anticancer and antibacterial activities

  2022cites this paper
• Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic Escherichia coli

  2021cites this paper
• Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic <italic toggle='yes'>Escherichia coli</italic>

  2021cites this paper
• Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research: Personalized Infectious Disease Medicine for the Most Vulnerable At-Risk Patients

  2020cites this paper
• Lack of Efficacy of the Neutropenic Diet in Decreasing Infections among Cancer Patients: A Systematic Review

  2020cites this paper
• Lipocalin2 Induced by Bacterial Flagellin Protects Mice against Cyclophosphamide Mediated Neutropenic Sepsis

  2020cites this paper
• Microbiome and host crosstalk: A new paradigm to cancer therapy.

  2020cites this paper
• Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract

  2020influential citation
• The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice.

  2020cites this paper
• The effects of neuroblastoma and chemotherapy on metabolism, fecal microbiome, volatile organic compounds, and gut barrier function in a murine model

  2019cites this paper
• Ginsenosides facilitate the anti-cancer efficacy of cyclophosphamide via modulating intestinal bacteria and alleviating intestinal mucositis in mammary carcinoma mice

  2019cites this paper
• Carboxymethyl pachyman (CMP) reduces intestinal mucositis and regulates the intestinal microflora in 5-fluorouracil-treated CT26 tumour-bearing mice.

  2018cites this paper
• Genomes of Escherichia coli bacteraemia isolates originating from urinary tract foci contain more virulence-associated genes than those from non-urinary foci and neutropaenic hosts

  2018cites this paper
• Context-Dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli

  2017cites this paper
• The role of polymorphonuclear neutrophils during HIV-1 infection

  2017cites this paper
• Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium

  2017influential citation
• Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of Bacteremia

  2017cites this paper
• Leading Edge Perspective Microbiome and Anticancer Immunosurveillance

  2016cites this paper
• Escherichia coli Free Radical-Based Killing Mechanism Driven by a Unique Combination of Iron Restriction and Certain Antibiotics

  2015cites this paper